On October 23, 2023, Elekta, a leader in precision radiation therapy, acquired Xoft from iCAD, Inc. ➡️https://bit.ly/492nPPv. Keep up to date on what’s new with our electronic brachytherapy technology by following the Elekta company page on LinkedIn.
关于我们
The Xoft® Electronic Brachytherapy System® is an isotope-free radiation treatment cleared by the FDA for use anywhere in the body, including non-melanoma skin cancer, brain tumors, early stage breast cancer, and gynecological cancers. It utilizes a proprietary miniaturized x-ray as the radiation source that delivers precise treatment directly to cancerous areas while sparing healthy tissue and organs. The Xoft System can be administered as a single course of radiation therapy during surgery in the form of intraoperative radiation therapy (IORT) or in the form of partial breast irradiation (APBI). The Xoft System does not require a shielded environment and the system’s relatively small size and mobility enable it to be used in virtually any clinical setting. A post-market study is underway to assess the safety and efficacy of IORT with the Xoft System. For more information about Xoft visit www.xoftinc.com.
- 网站
-
http://www.xoftinc.com
Xoft的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 51-200 人
- 总部
- San Jose,CA
- 类型
- 上市公司
- 创立
- 1998
- 领域
- Radiation Treatment、Electronic Brachytherapy (eBx)、Brachytherapy、Cancer Treatment、Healthcare、Breast Cancer、Skin Cancer、Endometrial Cancer、Intraoperative Radiation Therapy (IORT)、Accelerated Partial Breast Irradiation (APBI)、Skin Cancer和IORT
地点
-
主要
101 Nicholson Lane
US,CA,San Jose,95134